Nutricircle Ltd
₹ 395
-0.99%
16 Feb
- close price
- Market Cap ₹ 439 Cr.
- Current Price ₹ 395
- High / Low ₹ 411 / 89.8
- Stock P/E
- Book Value ₹ -0.22
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 62% |
| 3 Years: | 35% |
| 1 Year: | 76% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Feb - ENCLOSED HEREWITH NEWSPAPER PUBLICATION OF UN-AUDITED FINANCIAL RESULTS FOR QUARTER ENDED 31/12/2025
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 16 Feb
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 14 Feb
-
Announcement under Regulation 30 (LODR)-Allotment
13 Feb - Board approved 11,00,000 shares allotment to promoter Hitesh Patel; Rs82.5 lakh received on 13/02/2026.
- UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED 31/12/2025 13 Feb
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
NCL is an R&D based company engaged in isolating plant protein to enhance nutrition level of a wide range of food products viz. cereals, pulses, oil seeds, millets, etc.